DrugDashboards

Atorvastatin Calcium

Atorvastatin Calcium · ATORVASTATIN CALCIUM TRIHYDRATE 20 mg/1 · Tablet · Oral · Dr. Reddy's Laboratories Limited

NDC 55111-0122-05 · 500 TABLET in 1 BOTTLE · ANDA · View full market →

The short version

14 companies supply this market — deep enough that no single failure threatens the supply. The price is down 22% over the past year, to $0.0276 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.0276per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$0.1452per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$0.0370per TABweighted avg manufacturer price $0.0211 · Aug 1, 2026134% of what pharmacies pay — higher than 76% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.1$0.2Nov 2013Sep 2026$0.0276
155 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$0.83
#90 count
$2.49

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$40,410
5,986 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0● Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for atorvastatin calcium (oral solid) in the next 90 days

4 Class I/II recall(s) in 12 months · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA091650
TE code
AB
Approval date
Jul 17, 2012
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class III · TerminatedJun 4, 2021
    Dr. Reddy's Laboratories, Inc. — Failed Impurities/Degradation Specifications: due to presence of ATV cyclo IP and FP impurities
  • Class III · TerminatedMay 4, 2021
    Dr. Reddy's Laboratories, Inc. — Failed Impurities -Degradation Specifications:due to presence of ATV cyclo IP and FP impurities
  • Class III · TerminatedFeb 19, 2021
    Dr. Reddy's Laboratories, Inc. — Failed Impurities/Degradation Specifications:presence of ATV cyclo IP and FP, Dihydroxy epoxy and Dieto epoxy impurities
  • Class III · TerminatedAug 2, 2018
    Dr. Reddy's Laboratories, Inc. — Failed Impurities/Degradation Specifications - OOS was observed for ATV Cyclo FP Impurity and Total Degradation Impurities tested at the 18 month stability time point in Atorvastatin Calcium Tablets 40 mg 500 tablets.
  • Class III · TerminatedJun 12, 2018
    Dr. Reddy's Laboratories, Inc. — Failed Impurities/Degradation Specifications
  • Class III · TerminatedJun 12, 2018
    Dr. Reddy's Laboratories, Inc. — Failed Impurities/Degradation Specifications
  • Class III · TerminatedJun 12, 2018
    Dr. Reddy's Laboratories, Inc. — Failed Impurities/Degradation Specifications
  • Class III · TerminatedJan 29, 2018
    Dr. Reddy's Laboratories, Inc. — Failed Impurities/Degradations Specifications; out-of-specification results observed for Total Degradation Impurities during stability
  • Class III · TerminatedJan 29, 2018
    Dr. Reddy's Laboratories, Inc. — Failed Impurities/Degradations Specifications; out-of-specification results observed for Total Degradation Impurities during stability
  • Class III · TerminatedJan 29, 2018
    Dr. Reddy's Laboratories, Inc. — Failed Impurities/Degradations Specifications; out-of-specification results observed for Total Degradation Impurities during stability

Manufacturers of Atorvastatin Calcium (Tablet)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsATORVASTATIN CALCIUM TRIHYDRATE 80 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsATORVASTATIN CALCIUM TRIHYDRATE 40 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsATORVASTATIN CALCIUM TRIHYDRATE 10 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsATORVASTATIN CALCIUM TRIHYDRATE 20 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackATORVASTATIN CALCIUM TRIHYDRATE 20 mg/1Jul 15, 2026Sep 3, 2026
Dr. Reddy's Laboratories IncATORVASTATIN CALCIUM TRIHYDRATE 40 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackATORVASTATIN CALCIUM TRIHYDRATE 80 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackATORVASTATIN 80 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackATORVASTATIN 20 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackATORVASTATIN 40 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackATORVASTATIN CALCIUM TRIHYDRATE 40 mg/1Jul 15, 2026Sep 2, 2026
Coupler LLCATORVASTATIN CALCIUM TRIHYDRATE 20 mg/1Jul 15, 2026Sep 2, 2026
Coupler LLCATORVASTATIN CALCIUM TRIHYDRATE 10 mg/1Jul 15, 2026Sep 2, 2026
Direct RxATORVASTATIN CALCIUM TRIHYDRATE 40 mg/1Jul 15, 2026Sep 2, 2026
Direct_RxATORVASTATIN 10 mg/1Jul 15, 2026Sep 2, 2026
DirectRXATORVASTATIN 20 mg/1Jul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories LimitedATORVASTATIN CALCIUM TRIHYDRATE 20 mg/1Jul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories LimitedATORVASTATIN CALCIUM TRIHYDRATE 80 mg/1Jul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories LimitedATORVASTATIN CALCIUM TRIHYDRATE 40 mg/1Jul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories LimitedATORVASTATIN CALCIUM TRIHYDRATE 10 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedATORVASTATIN CALCIUM TRIHYDRATE 20 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedATORVASTATIN CALCIUM TRIHYDRATE 40 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedATORVASTATIN CALCIUM TRIHYDRATE 80 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedATORVASTATIN CALCIUM TRIHYDRATE 10 mg/1Jul 15, 2026Sep 2, 2026
Nivagen Pharmaceuticals, Inc.ATORVASTATIN 80 mg/1Jul 15, 2026Sep 2, 2026
Nivagen Pharmaceuticals, Inc.ATORVASTATIN 40 mg/1Jul 15, 2026Sep 2, 2026
Nivagen Pharmaceuticals, Inc.ATORVASTATIN 20 mg/1Jul 15, 2026Sep 2, 2026
Nivagen Pharmaceuticals, Inc.ATORVASTATIN 10 mg/1Jul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals,Inc.ATORVASTATIN 20 mg/1Jul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals,Inc.ATORVASTATIN CALCIUM TRIHYDRATE 40 mg/1Jul 15, 2026Sep 2, 2026
Proficient Rx LPATORVASTATIN 40 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.ATORVASTATIN CALCIUM TRIHYDRATE 20 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.ATORVASTATIN 80 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.ATORVASTATIN CALCIUM TRIHYDRATE 40 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.ATORVASTATIN 40 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.ATORVASTATIN 20 mg/1Jul 15, 2026Sep 2, 2026
Umedica Laboratories USA Inc.ATORVASTATIN 10 mg/1Jul 15, 2026Sep 2, 2026
Umedica Laboratories USA Inc.ATORVASTATIN 80 mg/1Jul 15, 2026Sep 2, 2026
Umedica Laboratories USA Inc.ATORVASTATIN 40 mg/1Jul 15, 2026Sep 2, 2026
Umedica Laboratories USA Inc.ATORVASTATIN 20 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Atorvastatin Calcium — NDC 55111-0122-05," retrieved September 3, 2026, https://drugdashboards.com/drug/55111012205.

Free to cite with attribution — see how the data is put together.